Barrett's Esophagus Clinical Trials
A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 349 clinical trials
A Phase 1 Open-Label Study to Evaluate the Safety Tolerability and Activity of AK002 in Patients with Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
This study is being done to see how safe the investigational new drug, AK002 is and how it affects your EG and/or EGE symptoms and the number of eosinophils in the stomach and the small intestine. This study will also be used to identify the best premedication and dose regimen …
- 0 views
- 19 Feb, 2024
- 1 location
Glioblastoma adaptive global innovative learning environment
This research study aims to evaluate multiple investigational treatments for either newly diagnosed or recurrent brain tumors to determine if any of these study treatment(s) improve overall survival as compared to standard treatments. The investigational drugs that will be used in this research study are temozolomide for newly diagnosed glioblastoma …
- 0 views
- 19 Feb, 2024
- 1 location
Prospective Elimination Of Distal Coronary Sinus-Left Atrial Connections for Atrial Fibrillation Ablation Trial
To achieve temporary arrhythmia suppression, repeated ablation procedures may be needed. The cost of AF ablation among Medicare patients followed for a year after ablation was found to be US$16,049±$12,536 if ablation was successful versus US$19,997±$13,958 for failed ablation.
- 0 views
- 19 Feb, 2024
- 1 location
Psoriasis Specimen BioBank
All prospective participants will have had to wash out for a specified time from psoriasis medications to be eligible (see protocol for specified washout time frames). Such a biobank will be critical to allowing us to deepen and expand existing collaborations between dermatology, rheumatology, immunology, and genetics to better define …
- 0 views
- 19 Feb, 2024
- 1 location
A Multicenter Randomized Double-blind Vehicle-controlled Phase 3 Efficacy and Safety Study of Patidegib Topical Gel 2% for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects with Basal Cell Nevus Syndrome
Additionally, the subject must have at least 2 BCCs with longest diameter 5 mm present on the face prior to randomization. The subject must be willing to abstain from application of a non-study topical medication (prescription or over the counter) to facial skin for the duration of the trial.
- 0 views
- 19 Feb, 2024
- 1 location
A Pilot Study of Network-Guided Transcranial Magnetic Stimulation for Adult ADHD
This within-subject proof of concept study will investigate whether TMS administered to two different networks thought to be involved in executive functions and attention can enhance specific functions in subjects with ADHD.
- 0 views
- 19 Feb, 2024
- 1 location
Skeletal Muscle Perfusion and Mitochondrial Function in Heart Failure with Preserved Ejection Fraction
The most common risks of participation are feeling uncomfortable in the MRI scanner due to lying still on the MRI table for prolonged periods of time, feeling claustrophobic in the MRI scanner (although your head will not be in the scanner), and minor leg discomfort from being asked to exercise …
- 0 views
- 19 Feb, 2024
- 1 location
A Multiple-Site Phase 1/2 Safety and Efficacy Trial of AGTC 402 a Recombinant Adeno-associated Virus Vector Expressing CNGA3 in Patients with Congenital Achromatopsia Caused by Mutations in the CNGA3 Gene
Achromatopsia is an inherited retinal disorder characterized by markedly reduced visual acuity, nystagmus, photoaversion (intolerance to bright light), a small central scotoma, eccentric viewing, and complete or severe loss of color discrimination. The genetic mutations of the disease can be established in the majority of individuals. Approximately 25% are caused …
- 0 views
- 19 Feb, 2024
- 1 location
mPeer2Peer
After each referral is made, seeds and their referred leads will be asked to answer a few questions about the referral interaction. The study will take a minimum of two weeks or a maximum of six weeks (for qualifying seeds).
- 0 views
- 19 Feb, 2024
- 1 location
A Phase 2 Study of ZEN003694 in Combination with Talazoparib in Patients with Triple-Negative Breast Cancer
What are well-tolerated doses of ZEN003694 and talazoparib that can be given together without causing significant side effects? 2. What are the side effects of ZEN003694 when combined with talazoparib?
- 0 views
- 19 Feb, 2024
- 1 location